Neffy nasal spray is shown in this undated photo. ARS PHARMA/HO Pharma
Meet Neffy, the needle-free nasal spray epinephrine used to treat anaphylaxis. It’s the first of its kind in Canada and it may very well pave the way for improving access to allergy care to come.
Host Maria Kestane speaks to Dr. Mariam Hanna, a pediatric allergist and clinical immunologist to discuss why Canada could be seeing an increase in allergies, what makes the Neffy so accessible and treatment-friendly, and why it’s taken us this long to get a budget friendly version of the life-saving drug on the market.
You can subscribe to The Big Story podcast on Apple Podcasts and Spotify.